Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ConocoPhillips
COP
|
+$3.16B |
| 2 |
Merck
MRK
|
+$2.72B |
| 3 |
SLB Ltd
SLB
|
+$1.62B |
| 4 |
Target
TGT
|
+$1.6B |
| 5 |
General Mills
GIS
|
+$930M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$2.81B |
| 2 |
Blackrock
BLK
|
+$2.57B |
| 3 |
US Bancorp
USB
|
+$1.84B |
| 4 |
M&T Bank
MTB
|
+$808M |
| 5 |
Huntington Bancshares
HBAN
|
+$595M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.45% |
| 2 | Financials | 11.9% |
| 3 | Healthcare | 10.6% |
| 4 | Consumer Discretionary | 9.01% |
| 5 | Industrials | 8.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1526
Check Point Software Technologies
CHKP
$13.1B
| $24.4M | ﹤0.01% |
107,197
+5,266
| +5% | +$1.12M |
|
1527
Procept Biorobotics
PRCT
$1.17B
| $24.3M | ﹤0.01% |
417,043
-9,391
| -2% | -$641K |
|
1528
CRISPR Therapeutics
CRSP
$5.17B
| $24.3M | ﹤0.01% |
713,539
-9,493
| -1% | -$402K |
|
1529
Zeta Global
ZETA
$6.69B
| $24.3M | ﹤0.01% |
1,788,769
-50,426
| -3% | -$901K |
|
1530
BlackLine
BL
$1.72B
| $24.2M | ﹤0.01% |
498,801
-2,898
| -0.6% | -$159K |
|
1531
The Bancorp
TBBK
$2.9B
| $24.1M | ﹤0.01% |
456,613
+10,468
| +2% | +$581K |
|
1532
GFL Environmental
GFL
$14.9B
| $24.1M | ﹤0.01% |
498,847
-11,681
| -2% | -$530K |
|
1533
Calix
CALX
$2.39B
| $24.1M | ﹤0.01% |
679,367
+30,123
| +5% | +$1.12M |
|
1534
Winnebago Industries
WGO
$909M
| $24.1M | ﹤0.01% |
698,647
+73,099
| +12% | +$3.1M |
|
1535
Gulfport Energy Corp
GPOR
$2.88B
| $24.1M | ﹤0.01% |
130,703
+25,871
| +25% | +$4.7M |
|
1536
CONMED
CNMD
$1.47B
| $24.1M | ﹤0.01% |
398,250
+15,300
| +4% | +$986K |
|
1537
Horace Mann Educators
HMN
$2.11B
| $24M | ﹤0.01% |
562,057
-4,823
| -0.9% | -$194K |
|
1538
Newmark Group
NMRK
$2.63B
| $23.9M | ﹤0.01% |
1,961,637
-144,526
| -7% | -$1.93M |
|
1539
SAP
SAP
$238B
| $23.9M | ﹤0.01% |
88,854
+12,359
| +16% | +$3.37M |
|
1540
IPG Photonics
IPGP
$3.84B
| $23.8M | ﹤0.01% |
377,598
+7,978
| +2% | +$536K |
|
1541
Nomad Foods
NOMD
$1.68B
| $23.8M | ﹤0.01% |
1,211,211
+70,344
| +6% | +$1.29M |
|
1542
Mirion Technologies
MIR
$3.91B
| $23.8M | ﹤0.01% |
1,641,075
+41,864
| +3% | +$658K |
|
1543
Standex International
SXI
$4.12B
| $23.8M | ﹤0.01% |
147,333
-1,562
| -1% | -$286K |
|
1544
Life Time Group Holdings
LTH
$9.79B
| $23.8M | ﹤0.01% |
787,109
+184,738
| +31% | +$5.43M |
|
1545
Boston Beer
SAM
$1.92B
| $23.8M | ﹤0.01% |
99,457
+5,101
| +5% | +$1.24M |
|
1546
Polaris
PII
$4.07B
| $23.7M | ﹤0.01% |
579,429
+24,122
| +4% | +$1.15M |
|
1547
Rhythm Pharmaceuticals
RYTM
$7.96B
| $23.6M | ﹤0.01% |
445,429
+5,179
| +1% | +$287K |
|
1548
BOK Financial
BOKF
$8.74B
| $23.6M | ﹤0.01% |
226,359
-4,549
| -2% | -$489K |
|
|
AKRO
1549
DELISTED
Akero Therapeutics
AKRO
| $23.6M | ﹤0.01% |
582,254
+41,562
| +8% | +$1.76M |
|
1550
Alamos Gold
AGI
$13.9B
| $23.6M | ﹤0.01% |
882,001
-36,427
| -4% | -$822K |
|
Similar funds
Charles Schwab's Q1 2025 Portfolio in Review
As of Q1 2025, Charles Schwab held 3,548 positions worth $533B, down 1.7% from $542B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q1 2025: portfolio turnover was 3.6%. Charles Schwab opened 55 new positions and exited 74, leaving the 3,548-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2025 buy was iShares Currency Hedged MSCI Eurozone ETF: 7,259,426 shares worth $283M.
- Charles Schwab added most to ConocoPhillips in Q1 2025, an estimated $3.16B increase.
- Charles Schwab's biggest Q1 2025 reduction was Pfizer, cutting an estimated $2.81B.
- Charles Schwab fully exited Brookfield in Q1 2025, selling an estimated $218M.
- Charles Schwab's ten largest holdings make up 20% of its $533B portfolio in Q1 2025.
- Charles Schwab opened 55 new positions and closed 74 in Q1 2025.
- Charles Schwab's portfolio value fell 1.7% quarter-over-quarter to $533B.
Based on Charles Schwab's 13F filing for Q1 2025, filed 9 May 2025.